In our recent report on Medical Devices Edwards Life Sciences was a top pick of Kristen M. Stewart,Vice President and Senior Analyst , Credit Suisse and here is why ;
Ms. Stewart: One company that I like at the present time is Edwards Lifesciences. It’s more of a mid-cap cardiovascular company. They are developing a new product, it’s called the transcatheter heart valve. They are selling it in Europe and are in clinical trials in the United States. It’s really one of the largest areas of new innovation. I think transcatheter heart valves can certainly be the next big thing in medical devices. It could be a multibillion-dollar market opportunity for a company of that size; that is very significant. These valves can really drive accelerating top- and bottom-line growth.
Make sure to follow us on TWITTER
Product Innovation Spurs Revenue Growth for IDEXX Laboratories, Inc. (IDXX)
May 14, 2015
Thoratic Corporation (THOR)’s Heart Devices Show Improved Survival for Patients; Market has Long-Term Opportunities
March 15, 2013
Personalized Medicine Changing the Game in Life Sciences
January 25, 2010
Government/Academic Research May Mean Greater Upside to Life Sciences Companies
January 27, 2010
Larger Names in Life Sciences Tools and Diagnostics to Boost Sector
August 21, 2012
